Advertisement
| drugs of abuse reference guide: Substance Abuse in America James A. Swartz, 2012-08-06 This book provides a comprehensive overview of drug policy in the United States from the early 1900s through the present day, providing historical and social context through the telling of the colorful and often tragic stories of the events and individuals throughout this period. Substance Abuse in America: A Documentary and Reference Guide examines the history of U.S. drug policy chronologically, from the early 1900s through the current day, covering topics such as patent medicines, Prohibition, Reefer Madness, the psychedelic '60s, Nixon's War on Drugs, and the powerful warring Mexican drug cartels that currently threaten political instability in that country. This book provides a comprehensive overview of U.S. drug policy that will fascinate general readers and benefit those in the field of substance abuse treatment or policy. Each chapter includes an analysis of a primary source document that serves to illuminate drug policy in America at a particular point in time as well as the reasons for the waxing and waning popularity of various drugs. The author provides accurate historical context that explains perceptions about substance abuse in American history, and draws compelling parallels across different time periods to show that much of what may seem new and unique for the present generation actually has a historical precedent. |
| drugs of abuse reference guide: Child and Adolescent Drug and Substance Abuse Louis A. Pagliaro, Ann Marie Pagliaro, 2019-11-01 By offering unique analysis and synthesis of theory, empirical research, and clinical guidance in an up-to-date and unbiased context, this book assists health and social care professionals in understanding the use of drugs and substances of abuse by children and adolescents. A comprehensive reference for health and social care professionals, the book identifies and corrects related false narratives and, with the use of the authors’ combined experience of over 70 years of clinical and academic experience in drug and substance abuse, provides current pharmacotherapeutic and psychotherapeutic approaches for the treatment of alcohol or other dependence or use disorders among children and adolescents. The book also provides a useful reference for identifying brand/trade and street names of the drugs and substances of abuse commonly used by children and adolescents. Also included is a comprehensive, cross-referenced subject index. Clear, comprehensive, accessible, and fully referenced, this book will be an invaluable resource for professionals and students who aim to treat children and adolescents. Child and Adolescent Drug and Substance Abuse is the 19th clinical pharmacology and therapeutic text that the Pagliaros have written over the past 40 years and is the sixth that deals exclusively with drug and substance abuse. |
| drugs of abuse reference guide: Critical Issues in Alcohol and Drugs of Abuse Testing Amitava Dasgupta, 2019-01-10 Critical Issues in Alcohol and Drugs of Abuse Testing, Second Edition, addresses the general principles and technological advances for measuring drugs and alcohol, along with the pitfalls of drugs of abuse testing. Many designer drugs, for example, are not routinely tested in drugs of abuse panels and may go undetected in a drug test. This updated edition is a must-have for clinical pathologists, toxicologists, clinicians, and medical review officers and regulators, bridging the gap between technical and clinical information. Topics of note include the monitoring of pain management drugs, bath salts, spices (synthetic marijuana), designer drugs and date rape drugs, and more. - Serves as a ready resource of information for alcohol and drug testing - Ideal resource for making decisions related to the monitoring and interpretation of results - Includes concise content for clinical laboratory scientists, toxicologists and clinicians |
| drugs of abuse reference guide: The Drug Expert Craig W. Stevens, 2020-01-08 The Drug Expert: A Practical Guide to the Impact of Drug Use in Legal Proceedings targets academic and industry pharmacologists, pharmacology graduate students, and professionals and students of affiliated disciplines, such as pharmacy and toxicology. Users will find it to be an invaluable reference for those involved in the field. In addition, pharmacists and others who increasingly serve as expert witnesses and toxicologists will find an array of very useful information. - Focuses on important topics for the consulting pharmacologist, including prescription, over-the-counter and illegal drugs and their effects on criminal and civil proceedings - Details the how-to aspects of being an expert witness in pharmacology by presenting real-life cases and effective tips and experiences - Includes several appendices, such as a sample letter of engagement and fee schedule, a litigation report, a consulting invoice and valuable resources |
| drugs of abuse reference guide: Drugs and Drug Abuse Terence Charles Cox, Terrence Charles Cox, Addiction Research Foundation of Ontario, 1983 |
| drugs of abuse reference guide: Handbook of Forensic Drug Analysis Fred Smith, 2004-12-31 The Handbook of Forensic Drug Analysis is a comprehensive chemical and analytic reference for the forensic analysis of illicit drugs. With chapters written by leading researchers in the field, the book provides in-depth, up-to-date methods and results of forensic drug analyses. This Handbook discusses various forms of the drug as well as the origin and nature of samples. It explains how to perform various tests, the use of best practices, and the analysis of results. Numerous forensic and chemical analytic techniques are covered including immunoassay, gas chromatography, and mass spectrometry. Topics range from the use of immunoassay technologies for drugs-of-abuse testing, to methods of forensic analysis for cannabis, hallucinogens, cocaine, opioids, and amphetamine. The book also looks at synthetic methods and law enforcement concerns regarding the manufacture of illicit drugs, with an emphasis on clandestine methamphetamine production. This Handbook should serve as a widely used reference for forensic scientists, toxicologists, pharmacologists, drug companies, and professionals working in toxicology testing labs, libraries, and poison control centers. It may also be used by chemists, physicians and those in legal and regulatory professions, and students of graduate courses in forensic science. - Contributed to by leading scientists from around the world - The only analysis book dedicated to illicit drugs of abuse - Comprehensive coverage of sampling methods and various forms of analysis |
| drugs of abuse reference guide: Medical Toxicology of Drug Abuse Donald G. Barceloux, 2012-02-03 This book provides a broad reference covering important drugs of abuse including amphetamines, opiates, and steroids. It also covers psychoactive plants such as caffeine, peyote, and psilocybin. It provides chemical structures, analytical methods, clinical features, and treatments of these drugs of abuse, serving as a highly useful, in-depth supplement to a general medical toxicology book. The style allows for the easy application of the contents to searchable databases and other electronic products, making this an essential resource for practitioners in medical toxicology, industrial hygiene, occupational medicine, pharmaceuticals, environmental organizations, pathology, and related fields. |
| drugs of abuse reference guide: Drugs, Brains, and Behavior , 2007 |
| drugs of abuse reference guide: User Accountability , 1992 |
| drugs of abuse reference guide: Drugs of Abuse Sherrel Howard, 2014-02-27 Drug abuse has been, and continues to be, a global societal issue with diverse sets of impacts. Drugs of Abuse: Pharmacology and Molecular Mechanisms introduces the basic principles of pharmacology and neuroscience of drug abuse. Understanding the chemistry of commonly abused drugs and their impact on brain function will provide students and researchers with a more profound understanding of the molecular basis of drug abuse and addiction. Drugs of Abuse: Pharmacology and Molecular Mechanisms opens with a brief history of drug use and abuse. Subsequent sections look at specific families of drugs, including stimulants, depressants, and hallucinogens among others, and explore how their chemical make-up interacts with brain function. The final chapter provides a brief overview of clinical substance abuse treatment. Providing a concise, accessible introductory overview of the topic, Drugs of Abuse: Pharmacology and Molecular Mechanisms will be a valuable resource for students, researchers, and others interested in how drugs interact with the brain. Introduces readers to the basic principles of neuroscience and pharmacology as related to drug use and abuse. Explores how the chemical make-up of drugs interact with the brain and can lead to addiction Includes coverage of a wide array of commonly abused families of drugs, including stimulants, depressants, hallucinogens, and others. Provides an essential introduction to the chemical and molecular underpinnings of drug use and abuse |
| drugs of abuse reference guide: Facing Addiction in America Office of the Surgeon General, U.s. Department of Health and Human Services, 2017-08-15 All across the United States, individuals, families, communities, and health care systems are struggling to cope with substance use, misuse, and substance use disorders. Substance misuse and substance use disorders have devastating effects, disrupt the future plans of too many young people, and all too often, end lives prematurely and tragically. Substance misuse is a major public health challenge and a priority for our nation to address. The effects of substance use are cumulative and costly for our society, placing burdens on workplaces, the health care system, families, states, and communities. The Report discusses opportunities to bring substance use disorder treatment and mainstream health care systems into alignment so that they can address a person's overall health, rather than a substance misuse or a physical health condition alone or in isolation. It also provides suggestions and recommendations for action that everyone-individuals, families, community leaders, law enforcement, health care professionals, policymakers, and researchers-can take to prevent substance misuse and reduce its consequences. |
| drugs of abuse reference guide: Top 300 Drugs Pocket Reference Guide (2024 Edition) Coventry House Publishing, 2024-07-23 The Top 300 Drugs Pocket Reference Guide serves as a portable reference to learn the essential information for the most commonly prescribed drugs. This on-the-go resource details the brand name, pharmacologic class, mechanism of action, dosage form, common use, and other clinical details for each drug. Whether you’re a pharmacy student or healthcare professional, this guide will serve as an effective resource to learn the basic characteristics of the most popular drugs. Drug details include: • Brand Names • Pharmacologic Classes • Mechanisms of Action • Common Uses • Dosage Forms • Dosing Information • Administration Methods • Monitoring Guidelines • Contraindications • Drug Interactions • Adverse Effects • Black Box Warnings |
| drugs of abuse reference guide: Illegal Drugs Paul Gahlinger, 2003-12-30 Does Ecstasy cause brain damage? Why is crack more addictive than cocaine? What questions regarding drugs are legal to ask in a job interview? When does marijuana possession carry a greater prison sentence than murder? Illegal Drugs is the first comprehensive reference to offer timely, pertinent information on every drug currently prohibited by law in the United States. It includes their histories, chemical properties and effects, medical uses and recreational abuses, and associated health problems, as well as addiction and treatment information. Additional survey chapters discuss general and historical information on illegal drug use, the effect of drugs on the brain, the war on drugs, drugs in the workplace, the economy and culture of illegal drugs, and information on thirty-three psychoactive drugs that are legal in the United States, from caffeine, alcohol and tobacco to betel nuts and kava kava. |
| drugs of abuse reference guide: A Guide to Substance Abuse Services for Primary Care Clinicians Eleanor J. Sullivan, 1997 EXECUTIVE SUMMARY AND RECOMMENDATIONS: The goal of this TIP is to recommend guidelines for primary care clinicians to follow in caring for patients with alcohol and other drug use disorders. These guidelines were developed by a Consensus Panel of clinicians, researchers, and educators who work on the prevention and treatment of substance use disorders. Protocols are based partly on research evidence, partly on Panel members' clinical experience. The algorithm to the left follows a patient with substance use problems who presents in a primary care setting. The chart will serve as a guide or road map through screening, brief assessment, brief intervention, assessment, referral, specialized treatment, and followup care as they are detailed in the TIP. Since substance use disorders are often chronic conditions that progress slowly over time, primary care clinicians, through their regular, long-term contact with patients, are in an ideal position to screen for alcohol and drug problems and monitor each patient's status. Futhermore, studies have found that primary care clinicians can actually help many patients decrease alcohol consumption and its harmful consequences through office-based interventions that take only 10 to 15 minutes (Kahan et al., 1995; Wallace et al., 1988). This potential, however, is largely untapped: Saitz and colleagues found that of a sample of patients seeking substance abuse treatment, 45 percent reported that their primary care physician was unaware of their substance abuse (Saitz et al., in press). Yet even though screening and limited treatment of substance use disorders do not require a large time investment, the Consensus Panel that developed this TIP recognized that many primary care clinicians are already overwhelmed by the demands imposed by expanded gatekeeper functions. The Panel realized that a practical approach to addressing patients' substance abuse problems was needed: one that recognized the time and resource limitations inherent in primary care practice and offered a series of graduates approaches that could be incorporated into a normal clinic or office routine. Biological, medical, and genetic factors as well as psychological, social, familial, cultural, and other environmental features all bear on substance abuse. Addressing the condition effectively requires a team effort, especially when it has progressed beyond the early stage. For this reason, in addition to screening and intervention treatment options, these guidelines include information about viable referral for assessment and treatment, as well as followup. Readers will notice that the TIP contains more information on alcohol use and abuse than on use of illicit drugs. This reflects both the scope of the problems and the research literature available about them. It is estimated that about 18 million people with alcohol use problems and 5 million users of illicit drugs need treatment. Although the Panel recognizes that tobacco is an addictive substance with a major public health impact, it is not included in this TIP because the topic falls outside CSAT's purview. Readers are referred to Smoking Cessation: a Guide for Primary Care Clinicians, published by the Agency for Health Care Policy and Research (Agency for Health Care Policy and Research, 1996). The Consensus Panel's recommendations are based on a combination of clinical experience and research-based evidence. In the list below, the summary guidelines supported by the research literature are followed by (1); clinically based recommendations are marked (2). Citations supporting the former are referenced in the body of the document. Screening and assessment instruments mentioned below are reproduced and discussed in Chapters 2 and 4 and Appendix C. The guidelines are presented in more detail in Chapter 6. |
| drugs of abuse reference guide: Alcohol and Other Drug Screening of Hospitalized Trauma Patients Peter O. Rostenberg, 1995 |
| drugs of abuse reference guide: Drugs and Drug Policy Mark A.R. Kleiman, Jonathan P. Caulkins, Angela Hawken, 2011-07-13 While there have always been norms and customs around the use of drugs, explicit public policies--regulations, taxes, and prohibitions--designed to control drug abuse are a more recent phenomenon. Those policies sometimes have terrible side-effects: most prominently the development of criminal enterprises dealing in forbidden (or untaxed) drugs and the use of the profits of drug-dealing to finance insurgency and terrorism. Neither a drug-free world nor a world of free drugs seems to be on offer, leaving citizens and officials to face the age-old problem: What are we going to do about drugs? In Drugs and Drug Policy, three noted authorities survey the subject with exceptional clarity, in this addition to the acclaimed series, What Everyone Needs to Know®. They begin, by defining drugs, examining how they work in the brain, discussing the nature of addiction, and exploring the damage they do to users. The book moves on to policy, answering questions about legalization, the role of criminal prohibitions, and the relative legal tolerance for alcohol and tobacco. The authors then dissect the illicit trade, from street dealers to the flow of money to the effect of catching kingpins, and show the precise nature of the relationship between drugs and crime. They examine treatment, both its effectiveness and the role of public policy, and discuss the beneficial effects of some abusable substances. Finally they move outward to look at the role of drugs in our foreign policy, their relationship to terrorism, and the ugly politics that surround the issue. Crisp, clear, and comprehensive, this is a handy and up-to-date overview of one of the most pressing topics in today's world. What Everyone Needs to Know® is a registered trademark of Oxford University Press. |
| drugs of abuse reference guide: Clinical Manual of Addiction Psychopharmacology, Second Edition Henry R. Kranzler, M.D., Domenic A. Ciraulo, M.D., Leah R. Zindel, R.Ph., M.A.L.S., 2013-11-06 This new edition of Clinical Manual of Addiction Psychopharmacology offers information on the pharmacology of the major classes of drugs related to addiction and the latest pharmacological treatment of dependence on these drugs. The manual reflects recent research and evidence-based perspectives on the pharmacological actions of drugs of abuse. |
| drugs of abuse reference guide: Workplace Drug Testing Alain G. Verstraete, 2011 This comprehensive text provides clear explanations of the effects of drugs on human performance and the need for workplace drug testing. It provides essential information on the regulatory and legal frameworks around the world, how to set policies and coverage of all aspects of drug analysis and the associated interpretation of results.Contents include:* epidemiology of drug use in the working population* the evidence base and guidelines for workplace drug testing* legal, regulatory aspects and policies for drugs and alcohol* urine and alternative sample collection process* analytical techniques and specimen adulteration.Case studies of successful programmes are also included to illustrate the principles discussed.Written by internationally acknowledged experts this informative book will be essential reading for anyone interested in workplace drug testing or setting up such a system including clinical and forensic toxicologists, occupational health physicians, nurses, human resources, drug counselling and treatment providers, analytical chemists and lawyers.Alain Verstraete is Professor at the Department of Clinical Chemistry, Microbiology and Immunology, Ghent University, Ghent, Belgium and Department Head of the Toxicology Laboratory of the Laboratory of Clinical Biology, Ghent University Hospital, Ghent, Belgium. |
| drugs of abuse reference guide: Encyclopedia of Substance Abuse Prevention, Treatment, and Recovery Gary L. Fisher, Nancy A. Roget, 2009 This collection provides authoritative coverage of neurobiology of addiction, models of addiction, sociocultural perspectives on drug use, family and community factors, prevention theories and techniques, professional issues, the criminal justice system and substance abuse, assessment and diagnosis, and more. |
| drugs of abuse reference guide: Pharmacology and Abuse of Cocaine, Amphetamines, Ecstasy and Related Designer Drugs Enno Freye, 2009-09-21 Finally - a book that covers all aspects of the illicit use of cocaine, amphetamines, ecstasy and/or designer drugs such as GHB, written by two experts in their field. The use of these drugs remains a continuous threat in health and medical care delivery, and this book will be an essential asset to the physician who may have to face the evaluation of patients whose use of these drugs compromises an effective treatment plan for other health issues. The book has been conceived to fill the void in existing physician reference materials, and provides a comprehensive review of the theoretical knowledge and scope of pharmacotherapy in individuals who are hooked on a psychoactive substance. While detailed scientific information is obtainable in other major articles, the book's straightforward format and style, along with its illustrations, will make for easy reading as emphasis is put on information specifically related to drugs that occur most abused in today’s society. The information provided is based on clinical practice rather than pure experimental data, which will give the physician more effective tools useful in their daily practice. Many mechanisms of action of abuse are described in detail and references are provided to direct the reader to further sources for additional information. As a special feature, the book incorporates uncluttered tables and charts, which result in immediate clarification of the mode of action on the central nervous system and the reason for misuse, thus avoiding usual long and fatiguing text in common reference books. The book aims to give the reader a clear and concise plan on what to do when being faced with an overdose situation. A well-organized Table of Contents rapidly leads the reader from general pharmacological issues to the specific overdose syndrome and its management. Additionally, significant emphasis is placed on the practical do's and don’ts for physicians, with special reference to the predictive signs of aberrant drug-related behavior and the identification of the drug diverter by using urine drug screening. |
| drugs of abuse reference guide: Evidence-Based Treatments for Alcohol and Drug Abuse Paul M. G. Emmelkamp, Ellen Vedel, 2012-10-12 Evidence-Based Treatments for Alcohol and Drug Abuse encompasses the developments in the field over the last decade, blending theory, techniques and clinical flexibility. Research in the past decade has shown that substance abuse and substance dependence are treatable. The field has witnessed the introduction of evidence-based psychological and specific pharmacological treatments. Unfortunately, many of the empirical supported therapies for addictions are still not widely applied by practitioners. The third volume in the Practical Clinical Guidebooks Series (PCG), Evidence-Based Treatments for Alcohol and Drug Abuse, defines the characteristics, classification, and prevalence of substance use disorders, and provides the clinician with practical guidelines applicable across a variety of treatment settings and patient groups. Drawing on the recent research in the field, the authors provide the practicing clinician and student with an up-to-date understanding of the epidemiology, etiology, course and prognosis of substance abuse disorders that would be relevant to clinical practice. In addition to describing phenomenology and etiology, the book provides a comprehensive guide to the assessment and treatment of DSM-IV-TR substance abuse disorders (SUDs), including abuse and dependence of alcohol, stimulants, opiates, hallucinogens, cannabis/marijuana, sedative, and party drugs. |
| drugs of abuse reference guide: Pocket Guide to Addiction Assessment and Treatment Petros Levounis, Erin Zerbo, Rashi Aggarwal, 2016-05-03 Ambivalence, poor adherence to treatment, serious psychiatric and medical comorbidities -- the difficulties posed by patients of substance use disorders are among the most challenging for practitioners to face. Given that only 10% of patients with these disorders actually receive specialized addiction treatment, it's clear that physicians in all medical and surgical specialties need to become comfortable assessing and treating substance use disorders. The Pocket Guide to Addiction Assessment and Treatment is designed specifically to aid a wide range of clinicians, regardless of their training in addiction, to more confidently assess and treat this patient population. The book's practical, actionable content is divided into three sections -- Fundamentals of Addiction, Substances and Behaviors, and Treatment -- that address topics including: The neurobiology of addiction How to recognize and treat intoxication, withdrawal from, and addiction to substances such as alcohol, anabolic-androgenic steroids, benzodiazepines, cannabis, opioids, stimulants, and tobacco, as well as hallucinogens, inhalants, and caffeine Special issues with psychiatric and medical comorbidities, as well as with specific populations Behavioral addictions, with a special focus on gambling disorder Cognitive-behavioral therapy; 12-step programs; nutrition and exercise; spirituality, mindfulness, and meditation; and other treatment options, with examples of how each can be used with patients facing addictions With an accessible, easily referenced format, the Pocket Guide to Addiction Assessment and Treatment serves as a go-to resource for general psychiatrists, internists, family practitioners, pediatricians, emergency medicine physicians, psychiatric nurses, residents, medical students, and other practitioners involved in the addiction treatment field. And because all of the diagnostic discussions are DSM-5®--based, readers can be confident that they're getting the most relevant and up-to-date guidance on the topic. |
| drugs of abuse reference guide: The Quick-Reference Guide to Addictions and Recovery Counseling Dr. Tim Clinton, Dr. Eric Scalise, 2013-10-15 The newest addition to the popular Quick-Reference Guide collection, The Quick-Reference Guide to Addictions and Recovery Counseling focuses on the widespread problem of addictions of all kinds. It is an A-Z guide for assisting pastors, professional counselors, and everyday believers to easily access a full array of information to aid them in formal and informal counseling situations. Each of the forty topics covered follows a helpful eight-part outline and identifies (1) typical symptoms and patterns, (2) definitions and key thoughts, (3) questions to ask, (4) directions for the conversation, (5) action steps, (6) biblical insights, (7) prayer starters, and (8) recommended resources. |
| drugs of abuse reference guide: Urine Testing for Drugs of Abuse , 1986 |
| drugs of abuse reference guide: Karch's Pathology of Drug Abuse Steven B. Karch MD, Olaf Drummer, Steven B. Karch MD FFFLM, 2001-12-26 AUTHORITATIVE INFORMATION FROM THE SOURCE YOU TRUST The third edition of Karch's Pathology of Drug Abuse continues to provide a comprehensive yet accessible guide to the pathology, toxicology, and pharmacology of commonly abused drugs. As in previous editions, the focus remains on the investigation of drug-related deaths and on practical app |
| drugs of abuse reference guide: Absolute Addiction Psychiatry Review Carla Marienfeld, 2020-03-06 This book serves as a tool for general psychiatrists, medical students, residents, and fellows looking for a clinically relevant and high-yield overview of addiction psychiatry in preparation for their board exams – or for everyday clinical practice. Written by expert educators in addiction psychiatry, the text is organized by substances misused and populations affected. This book serves as both a primary learning tool for those new to the field, as well as a reference for those working in addiction treatment. Each chapter begins with summaries of high yield clinical pearls, followed by general information including treatment, and then ends with accompanying board-style review questions. The scope includes understanding substances of misuse and substance use disorders (SUDs), how to evaluate, diagnose, and monitor SUDs, how to treat SUDs both pharmacologically and behaviorally, and critical information for specific populations of patients. Absolute Addiction Psychiatry for Clinical Practice and Review is an excellent resource for all medical students, residents, fellows, and professionals taking certification exams in addiction, including those in psychiatry, addiction medicine, emergency medicine, internal medicine, pain medicine, and others. The chapter Laboratory Testing for Substance Use Disorders is available open access under a Creative Commons Attribution 4.0 International License via link.springer.com. |
| drugs of abuse reference guide: Pain Management and the Opioid Epidemic National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Health Sciences Policy, Committee on Pain Management and Regulatory Strategies to Address Prescription Opioid Abuse, 2017-09-28 Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring. |
| drugs of abuse reference guide: Results from the ... National Survey on Drug Use and Health National Survey on Drug Use and Health (U.S.), 2002 |
| drugs of abuse reference guide: Guide to Psychoactive Drugs Richard B Seymour, David E Smith, 2013-01-11 Invaluable clinical and treatment information on the most powerful mind-altering drugs in use today. Compiled by two leading professionals from the renowned Haight Ashbury Clinic, the information is based on national and international studies undertaken at the clinic, as well as from 600,000 patient visits, a thorough review of practice and background as reported in the literature, and from their own private practices. An up-to-date reference source, this important guide includes information on the trademark, generic, and popular names of drugs; the use and abuse of drugs; and their acute and chronic effects. An innovative index and cross reference system provide quick, easy access for the physician who must act quickly in an emergency. |
| drugs of abuse reference guide: Drugs and Drug Policy Clayton J. Mosher, Scott Akins, 2007 Drugs and Drug Policy: The Control of Consciousness Alteration provides a cross-national perspective on the regulation of drug use by examining and critiquing drug policies in the United States and abroad in terms of their scope, goals, and effectiveness. In this engaging text, authors Clayton J. Mosher and Scott Akins discuss the physiological, psychological, and behavioral effects of legal and illicit drugs; the patterns and correlates of use; and theories of the causes of drug use. Key Features: * Offers more coverage of drug policy issues than competitive books: This book addresses the number of significant developments over the last few decades that suggest the dynamics of drug use and policies to deal with drug use are at a critical juncture. The book also considers the issue of American exceptionalism with respect to drug policies through a detailed analysis of emerging drug polices in other Western nations. * Makes explicit comparisons between legal and illegal drugs: Due to their prevalence of use, this book devotes considerable attention to the use and regulation of legal drugs in society. The book illustrates that commonly prescribed medications are similar to drugs that are among the most feared and harshly punished in society and that drug-related problems do not necessarily result from particular drugs, but from how drugs are used. * Includes many pedagogical tools: With chapter opening photos and more photos throughout, this text presents material in a student- friendly fashion. Highlight boxes provide interesting examples for readers; encourage further emphasis on issues; and serve as important topics for in class writing exercises. In addition, Internet exercises and review questions reinforce key points made in the chapter and prompt classroom discussion. |
| drugs of abuse reference guide: A Comprehensive Guide to Toxicology in Nonclinical Drug Development Ali S. Faqi, 2016-11-03 A Comprehensive Guide to Toxicology in Nonclinical Drug Development, Second Edition, is a valuable reference designed to provide a complete understanding of all aspects of nonclinical toxicology in the development of small molecules and biologics. This updated edition has been reorganized and expanded to include important topics such as stem cells in nonclinical toxicology, inhalation and dermal toxicology, pitfalls in drug development, biomarkers in toxicology, and more. Thoroughly updated to reflect the latest scientific advances and with increased coverage of international regulatory guidelines, this second edition is an essential and practical resource for all toxicologists involved in nonclinical testing in industry, academic, and regulatory settings. - Provides unique content that is not always covered together in one comprehensive resource, including chapters on stem cells, abuse liability, biomarkers, inhalation toxicology, biostatistics, and more - Updated with the latest international guidelines for nonclinical toxicology in both small and large molecules - Incorporates practical examples in order to illustrate day-to-day activities and the expectations associated with working in nonclinical toxicology |
| drugs of abuse reference guide: Drugs and Addictive Behaviour Hamid Ghodse, 2002-10-24 In this completely revised and updated third edition of his highly successful book, Hamid Ghodse presents a comprehensive overview of substance misuse and dependence. There is a particular emphasis on practical, evidence-based approaches to the assessment and management of a wide range of drug-related problems in a variety of clinical settings, and he has written an entirely new chapter on alcohol abuse. He defines all the terms, and describes the effects of substance misuse on a patient's life. Epidemiology, and international prevention and drug control policies are covered to address the global nature of the problem, and the appendix provides a series of clinical intervention tools, among them a Substance Misuse Assessment Questionnaire. This will be essential reading for all clinicians and other professionals dealing with addiction, from counsellors and social workers to policy makers. |
| drugs of abuse reference guide: TIP 35: Enhancing Motivation for Change in Substance Use Disorder Treatment (Updated 2019) U.S. Department of Health and Human Services, 2019-11-19 Motivation is key to substance use behavior change. Counselors can support clients' movement toward positive changes in their substance use by identifying and enhancing motivation that already exists. Motivational approaches are based on the principles of person-centered counseling. Counselors' use of empathy, not authority and power, is key to enhancing clients' motivation to change. Clients are experts in their own recovery from SUDs. Counselors should engage them in collaborative partnerships. Ambivalence about change is normal. Resistance to change is an expression of ambivalence about change, not a client trait or characteristic. Confrontational approaches increase client resistance and discord in the counseling relationship. Motivational approaches explore ambivalence in a nonjudgmental and compassionate way. |
| drugs of abuse reference guide: Psychological Treatment of Medical Patients Struggling with Harmful Substance Use Julie A. Schumacher, Daniel C. Williams, 2019-10-08 This book shows mental health providers how to assess and treat substance use in medical settings. Clinical health psychologists often encounter patients needing interventions for substance use, yet rarely do practitioners receive specialized training in this area. Psychological Treatment of Medical Patients With Harmful Substance Use is designed for mental health providers in medical settings who need the knowledge and skills to assess and treat conditions relevant to substance use. This book is especially useful for mental health providers who treat adult medical outpatients for whom substance use is not their primary presenting problem. The authors clarify the distinction between nonharmful and harmful substance use, describe the signs and symptoms of substance use disorders, epidemiology, current models denoting biological and socio-cultural causes, and contributing factors (with an emphasis on cardiac, cancer, women's health, and primary care settings). They offer best-practice assessment strategies, and psychological, self-help and pharmacological treatments. Chapters also describe assessment and intervention for conditions that are often comorbid with substance use, including depression, anxiety, and sleep dysregulation, as well as treatment for family members who are dealing with a loved one's harmful substance use, relapse prevention and continuing care. |
| drugs of abuse reference guide: Treatment Improvement Protocol (TIP) 63: Medications for Opioid Use Disorder Substance Abuse Mental Health Services Administration/SAMHSA (U.S.), 2018-06-05 This Treatment Improvement Protocol (TIP) reviews the use of the three Food and Drug Administration (FDA)-approved medications used to treat opioid use disorder (OUD)—methadone, naltrexone, and buprenorphine—and provides guidance for healthcare professionals and addiction treatment providers on appropriate prescribing practices for these medications and effective strategies for supporting the patients utilizing medication for the treatment of OUD. The goal of treatment for opioid addiction or OUD is remission of the disorder leading to lasting recovery. Recovery is a process of change through which individuals improve their health and wellness, live self-directed lives, and strive to reach their full potential. This TIP also educates patients, families, and the general public about how OUD medications work and the benefits they offer. Related products: Medication-Assisted Treatment of Opioid Use Disorder: Pocket Guide A Shared Burden: The Military and Civilian Consequences of Army Pain Management Since 2001 Click our Alcoholism, Smoking & Substance Abuse collection to find more resources on this topic. |
| drugs of abuse reference guide: Substance Abuse Sheri Mabry Bestor, Sheri Mabry, 2013 Looks at the various reasons why young people experiment with drugs and alchohol and the consequences of doing so--P. 4 of cover. |
| drugs of abuse reference guide: Buzzed Cynthia Kuhn, Scott Swartzwelder, Wilkie Wilson, Leigh Heather Wilson, Jeremy Foster, 1998 Based on the most current psychological and pharmacological research, provides a reliable, unbiased look at the use and abuse of legal and illegal drugs -- from alcohol, caffeine, and anti-anxiety pills to heroin, ecstasy, and special-K. |
| drugs of abuse reference guide: Handbook of Substance Misuse and Addictions Vinood B. Patel, Victor R. Preedy, 2022-11-12 Substance misuse and addictions are a public health issue. They affect the well-being of each community and nation as a whole. It is, therefore, necessary to identify, educate, and treat individuals who are addicted to substances. Policies and procedures go hand-in-hand with public health education and safety. The science behind the public health issues of one drug may be applicable to other drugs as well. However, marshalling all of the aforementioned information into a single source is somewhat difficult due to the wide array of material. The Editors address this by compiling the research in this single reference work that serves as a one-stop-shopping approach to everything readers need to know about the scientific basis of public health and addictions and agents of misuse. Apart from active agents that have a plant or chemical basis, there is a need to consider that there are other forms of addiction which may have common modes of causality or prevention. These include food addiction, gaming, gambling, and other non-drug addictions. These types of addiction may be related to the addiction of drugs. Overall, the Handbook of Substance Misuse and Addictions: From Biology to Public Health offers a holistic understanding of the relationship between public health and substance misuse. The text provides a common platform upon which other forms of addiction or substance misuse can be understood and treated. Addiction processes involve understanding the biological processes as well as behavior, psychology, sociology, and public health, all of which are interlinked. This Handbook is a useful reference for lecturers, students, researchers, practitioners, and other professionals in public health, addiction science, epidemiology, health education, health promotion, and health sciences. |
| drugs of abuse reference guide: Substance Abuse in America James A. Swartz, 2012-08-06 This book provides a comprehensive overview of drug policy in the United States from the early 1900s through the present day, providing historical and social context through the telling of the colorful and often tragic stories of the events and individuals throughout this period. Substance Abuse in America: A Documentary and Reference Guide examines the history of U.S. drug policy chronologically, from the early 1900s through the current day, covering topics such as patent medicines, Prohibition, Reefer Madness, the psychedelic '60s, Nixon's War on Drugs, and the powerful warring Mexican drug cartels that currently threaten political instability in that country. This book provides a comprehensive overview of U.S. drug policy that will fascinate general readers and benefit those in the field of substance abuse treatment or policy. Each chapter includes an analysis of a primary source document that serves to illuminate drug policy in America at a particular point in time as well as the reasons for the waxing and waning popularity of various drugs. The author provides accurate historical context that explains perceptions about substance abuse in American history, and draws compelling parallels across different time periods to show that much of what may seem new and unique for the present generation actually has a historical precedent. |
| drugs of abuse reference guide: The Medical Review Officers Manual Robert B. Swotinsky, 2021-07 |
Drugs (psychoactive) - World Health Organization (WHO)
Jun 25, 2024 · Psychoactive drugs are substances that, when taken in or administered into one's system, affect mental processes, e.g. cognition or affect. This term and its equivalent, …
WHO Drug Information - World Health Organization (WHO)
About WHO Drug Information. WHO Drug Information is a quarterly journal providing an overview of topics relating to medicines development and regulation which is targeted to a wide …
基本药物 - World Health Organization (WHO)
Sep 25, 2024 · 基本药物是有效安全地满足人民医疗保健需求的药物。世卫组织根据公共卫生相关性、有关益处和危害的证据并考虑成本、负担能力和其他相关因素来选择基本药物。
Alcohol, Drugs and Addictive Behaviours - World Health …
Nov 3, 1994 · Alcohol, Drugs and Addictive Behaviours The Unit works globally to improve health and well-being of populations by articulating, promoting, supporting and monitoring evidence …
UN Commission approves WHO recommendations to place …
Mar 13, 2025 · “We are pleased that the Commission (on Narcotic Drugs) has accepted the full set of WHO recommendations and added these substances to relevant schedules in the 1961 …
COVID-19 Treatments - World Health Organization (WHO)
Apr 16, 2025 · Thousands of trials investigating COVID-19 interventions have been registered or are ongoing. WHO, through its COVID-19 Solidarity Therapeutics Trial, is coordinating global …
Medicines - World Health Organization (WHO)
Today there are thousands of drugs on the market able to prevent, treat and lessen the impact of ailments that would have been fatal just a few generations ago. At the same time, antimicrobial …
Health products policy and standards - World Health Organization …
Nonproprietary names are intended for use in pharmacopoeias, labelling, product information, advertising and other promotional material, drug regulation and scientific literature, and as a …
WHO Model Lists of Essential Medicines
Jul 26, 2023 · Short description: The eEML is a comprehensive, freely accessible, online database containing information on essential medicines.
Antifungal agents in clinical and preclinical development: overview …
Apr 1, 2025 · This report presents the first World Health Organization (WHO) analysis of antifungal agents in preclinical and clinical development. It covers systemic antifungal drugs in …
Drugs (psychoactive) - World Health Organization (WHO)
Jun 25, 2024 · Psychoactive drugs are substances that, when taken in or administered into one's system, affect mental processes, e.g. cognition or affect. This term and its equivalent, …
WHO Drug Information - World Health Organization (WHO)
About WHO Drug Information. WHO Drug Information is a quarterly journal providing an overview of topics relating to medicines development and regulation which is targeted to a wide audience of …
基本药物 - World Health Organization (WHO)
Sep 25, 2024 · 基本药物是有效安全地满足人民医疗保健需求的药物。世卫组织根据公共卫生相关性、有关益处和危害的证据并考虑成本、负担能力和其他相关因素来选择基本药物。
Alcohol, Drugs and Addictive Behaviours - World Health …
Nov 3, 1994 · Alcohol, Drugs and Addictive Behaviours The Unit works globally to improve health and well-being of populations by articulating, promoting, supporting and monitoring evidence …
UN Commission approves WHO recommendations to place …
Mar 13, 2025 · “We are pleased that the Commission (on Narcotic Drugs) has accepted the full set of WHO recommendations and added these substances to relevant schedules in the 1961 or 1971 …
COVID-19 Treatments - World Health Organization (WHO)
Apr 16, 2025 · Thousands of trials investigating COVID-19 interventions have been registered or are ongoing. WHO, through its COVID-19 Solidarity Therapeutics Trial, is coordinating global efforts …
Medicines - World Health Organization (WHO)
Today there are thousands of drugs on the market able to prevent, treat and lessen the impact of ailments that would have been fatal just a few generations ago. At the same time, antimicrobial …
Health products policy and standards - World Health Organization …
Nonproprietary names are intended for use in pharmacopoeias, labelling, product information, advertising and other promotional material, drug regulation and scientific literature, and as a …
WHO Model Lists of Essential Medicines
Jul 26, 2023 · Short description: The eEML is a comprehensive, freely accessible, online database containing information on essential medicines.
Antifungal agents in clinical and preclinical development: overview …
Apr 1, 2025 · This report presents the first World Health Organization (WHO) analysis of antifungal agents in preclinical and clinical development. It covers systemic antifungal drugs in …
